A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Study Participants With Active Psoriatic Arthritis

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

684

Participants

Timeline

Start Date

October 21, 2024

Primary Completion Date

March 18, 2026

Study Completion Date

July 8, 2026

Conditions
Psoriatic Arthritis
Interventions
DRUG

Bimekizumab

Study participants will receive bimekizumab at pre-specified time points.

DRUG

Risankizumab

Study participants will receive risankizumab at pre-specified time points.

DRUG

Placebo

Study participants will receive placebo at pre-specified time points.

Trial Locations (142)

11201

Pa0016 50666, Brooklyn

16635

Pa0016 50652, Duncansville

19610

Pa0016 50006, Wyomissing

21740

Pa0016 50686, Hagerstown

32174

Pa0016 50059, Ormond Beach

33189

Pa0016 50679, Cutler Bay

33309

Pa0016 50685, Fort Lauderdale

33324

Pa0016 50324, Plantation

33511

Pa0016 50239, Brandon

33542

Pa0016 50678, Zephyrhills

33765

Pa0016 50630, Clearwater

38305

Pa0016 50001, Jackson

45044

Pa0016 50664, Middletown

45377

Pa0016 50680, Vandalia

48081

Pa0016 50551, Saint Clair Shores

48910

Pa0016 50665, Lansing

53217

Pa0016 50674, Glendale

55121

Pa0016 50689, Eagan

60076

Pa0016 50651, Skokie

60527

Pa0016 50650, Willowbrook

63141

Pa0016 50016, St Louis

64151

Pa0016 50682, Kansas City

75390

Pa0016 50687, Dallas

76109

Pa0016 50673, Fort Worth

77375

Pa0016 50655, Tomball

77521

Pa0016 50048, Baytown

79424

Pa0016 50657, Lubbock

85032

Pa0016 50058, Phoenix

85297

Pa0016 50662, Gilbert

85306

Pa0016 50062, Glendale

85351

Pa0016 50131, Sun City

87102

Pa0016 50653, Albuquerque

90404

Pa0016 50672, Santa Monica

91722

Pa0016 50654, Covina

92037

Pa0016 50301, La Jolla

92128

Pa0016 50663, San Diego

98104

Pa0016 50027, Seattle

99204

Pa0016 50061, Spokane

Unknown

Pa0016 30002, Clayton

Pa0016 30034, Footscray

Pa0016 30033, Heidelberg

Pa0016 30003, Maroochydore

Pa0016 30032, Parramatta

Pa0016 30009, Westmead

Pa0016 40313, Pleven

Pa0016 40006, Plovdiv

Pa0016 40813, Plovdiv

Pa0016 40818, Plovdiv

Pa0016 40820, Plovdiv

Pa0016 40656, Rousse

Pa0016 40823, Rousse

Pa0016 40314, Sofia

Pa0016 40380, Sofia

Pa0016 40811, Sofia

Pa0016 40819, Sofia

Pa0016 50041, Québec

Pa0016 50658, St. John's

Pa0016 50044, Trois-Rivières

Pa0016 40065, Brno

Pa0016 40062, Moravska Ostrava A Privoz

Pa0016 40802, Ostrava

Pa0016 40066, Prague

Pa0016 40801, Prague

Pa0016 40010, Uherské Hradiště

Pa0016 40012, Zlín

Pa0016 40073, Bad Nauheim

Pa0016 40025, Berlin

Pa0016 40515, Berlin

Pa0016 40138, Bonn

Pa0016 40808, Cologne

Pa0016 40072, Freiburg im Breisgau

Pa0016 40029, Hamburg

Pa0016 40810, Herne

Pa0016 40724, München

Pa0016 40800, Ratingen

Pa0016 40814, Tübingen

Pa0016 40081, Budapest

Pa0016 40804, Budapest

Pa0016 40809, Hódmezővásárhely

Pa0016 40031, Szeged

Pa0016 20035, Bunkyō City

Pa0016 20043, Itabashi-ku

Pa0016 20045, Kita-gun

Pa0016 20049, Kitakyushu

Pa0016 20069, Meguro-ku

Pa0016 20336, Mitaka-shi

Pa0016 20033, Nagoya

Pa0016 20041, Osaka

Pa0016 20046, Osaka

Pa0016 20031, Sapporo

Pa0016 20335, Yokohama

Pa0016 40789, Bialystok

Pa0016 40791, Bialystok

Pa0016 40824, Bialystok

Pa0016 40119, Bydgoszcz

Pa0016 40798, Bydgoszcz

Pa0016 40038, Elblag

Pa0016 40795, Katowice

Pa0016 40092, Krakow

Pa0016 40490, Krakow

Pa0016 40502, Krakow

Pa0016 40792, Krakow

Pa0016 40037, Lublin

Pa0016 40483, Nadarzyn

Pa0016 40091, Nowa Sól

Pa0016 40796, Olsztyn

Pa0016 40794, Opole

Pa0016 40044, Poznan

Pa0016 40090, Poznan

Pa0016 40807, Poznan

Pa0016 40790, Sochaczew

Pa0016 40788, Torun

Pa0016 40094, Warsaw

Pa0016 40394, Warsaw

Pa0016 40539, Warsaw

Pa0016 40604, Warsaw

Pa0016 40793, Warsaw

Pa0016 40797, Warsaw

Pa0016 40043, Wroclaw

Pa0016 40095, Wroclaw

Pa0016 40805, Wroclaw

Pa0016 40806, A Coruña

Pa0016 40269, Bilbao

Pa0016 40105, Córdoba

Pa0016 40231, Madrid

Pa0016 40102, Málaga

Pa0016 40803, Sabadell

Pa0016 40753, Santiago de Compostela

Pa0016 40049, Seville

Pa0016 40799, Seville

Pa0016 40099, Vigo

Pa0016 40833, Barnet

Pa0016 40829, Cambridge

Pa0016 40281, Leeds

Pa0016 40113, London

Pa0016 40827, Luton

Pa0016 40237, Manchester

Pa0016 40306, Newcastle upon Tyne

Pa0016 40812, Peterborough

Pa0016 40828, Reading

Pa0016 40108, Salford

Pa0016 40825, Wolverhampton

All Listed Sponsors
lead

UCB Biopharma SRL

INDUSTRY

NCT06624228 - A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Study Participants With Active Psoriatic Arthritis | Biotech Hunter | Biotech Hunter